Сlinical and laboratory features of vaccination against COVID-19 in pregnant women

Abstract

Тo evaluate the safety, efficacy, and immunogenicity of COVID-19 vaccination in pregnant women. Materials and research methods. The study included 120 pregnant women vaccinated with the Gam-Kovid-Vak vaccine against COVID-19. Of these, 60 women were vaccinated in the second trimester of pregnancy (main group I) and 60 in the third trimester of pregnancy (main group II), and the comparison group consisted of 30 pregnant women who refused vaccination.